Startups

Karma Biotechnologies logo

Karma Biotechnologies

Torrance, California · Los Angeles, California

Karma Biotechnologies is a Los Angeles biotech company founded in 2017. It developed lipid-nanoparticle immunotherapies (Xavine) aimed at autoimmunity and solid tumors. Founders include Andrew Gray (CEO), Alan Johnson (COO) and Joseph Turner. PitchBook lists the company as out of business as of 25 Jul 2025.

Founded 2017

Team

Alan JohnsonAlan JohnsonCo-Founder and VP Production
Andrew GrayAndrew GrayCo-Founder and CEO
Joseph TurnerJoseph TurnerPresident, CFO and CBO

Investments

$—2023-05-31SOSV
$—2019-09-03Khosla Ventures, Vinod Khosla, IndieBio, Gaingels, MarsBio